Cargando…

Reproducibility of a prediabetes classification in a contemporary population

AIMS: To assess whether meeting both fasting plasma glucose (FPG) and HbA1c criteria for prediabetes in people at high risk indicates with near certainty the presence of dysglycemia on repeat testing. METHODS: Observational study using data from Vitamin D and Type 2 Diabetes (D2d) study. HbA1c, FPG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chadha, Chhavi, Pittas, Anastassios G., Lary, Christine W., Knowler, William C., Chatterjee, Ranee, Phillips, Lawrence S., Aroda, Vanita R., Lewis, Michael R., Pratley, Richard, Staten, Myrlene A., Nelson, Jason, Rasouli, Neda, Brodsky, Irwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424833/ https://www.ncbi.nlm.nih.gov/pubmed/32812912 http://dx.doi.org/10.1016/j.metop.2020.100031

Ejemplares similares

Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590–1599
por: LeBlanc, Erin S., et al.
Publicado: (2019)

Management of Hemoglobin Variants Detected Incidentally in HbA(1c) Testing: A Common Problem Currently Lacking a Standard Approach
por: Lewis, Michael R., et al.
Publicado: (2017)

Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study
por: Dawson-Hughes, Bess, et al.
Publicado: (2020)

Response to Comment on Lewis et al. Management of Hemoglobin Variants Detected Incidentally in HbA(1c) Testing: A Common Problem Currently Lacking a Standard Approach. Diabetes Care 2017;40:e8–e9
por: Lewis, Michael R., et al.
Publicado: (2017)

Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial
por: Pittas, Anastassios G., et al.
Publicado: (2014)

Financial management of large, multi-center trials in a challenging funding milieu
por: Lovegreen, Olivia, et al.
Publicado: (2018)

Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort
por: Kashyap, Sangeeta R., et al.
Publicado: (2023)

Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes
por: Johnson, Karen C., et al.
Publicado: (2022)

Correction to: Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes
por: Johnson, Karen C., et al.
Publicado: (2022)

A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes
por: Aroda, Vanita R., et al.
Publicado: (2022)

Response to Comment on Dawson-Hughes et al. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916–2922
por: Dawson-Hughes, Bess, et al.
Publicado: (2021)

Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk
por: Chatterjee, Ranee, et al.
Publicado: (2013)

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes
por: Hill, James O., et al.
Publicado: (2013)

Using Oral Challenge Testing to Assess Insulin Action and Secretion With Mathematical Modeling
por: Staten, Myrlene A., et al.
Publicado: (2014)

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses
por: Pratley, Richard E, et al.
Publicado: (2020)

Untangling the Gordian Knot of Vitamin D Supplementation and Type 2 Diabetes Prevention
por: Pittas, Anastassios G., et al.
Publicado: (2020)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

Diabetes and Risk of Non-Hodgkin's Lymphoma: A meta-analysis of observational studies
por: Mitri, Joanna, et al.
Publicado: (2008)

SAT142 Utilization Of Continuous Glucose Monitoring In Diagnosis And Management Of Insulinoma
por: Phan, Van, et al.
Publicado: (2023)

Metformin and Type 2 Diabetes Prevention
por: Aroda, Vanita R., et al.
Publicado: (2018)

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale
por: Yassin, Sayf A, et al.
Publicado: (2017)

Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment
por: Aroda, Vanita R., et al.
Publicado: (2022)

Multi-dimensional characterization of prediabetes in the Project Baseline Health Study
por: Chatterjee, Ranee, et al.
Publicado: (2022)

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
por: Aroda, Vanita R., et al.
Publicado: (2018)

Post-thyroidectomy hypocalcemia exacerbated by chyle leak
por: Alzaman, Naweed, et al.
Publicado: (2015)

Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D?
por: Pittas, Anastassios G, et al.
Publicado: (2020)

Response to Letter to the Editor from Dalan: “Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D?”
por: Pittas, Anastassios G, et al.
Publicado: (2020)

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
por: Phan, Van, et al.
Publicado: (2022)

Combining Wireless Technology and Behavioral Economics to Engage Patients (WiBEEP) with cardiometabolic disease: a pilot study
por: Angellotti, Edith, et al.
Publicado: (2019)

Insulin Assay Standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care
por: Staten, Myrlene A., et al.
Publicado: (2010)

Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A(1c) Targets?
por: Shahraz, Saeid, et al.
Publicado: (2016)

Upper and/or lower gastrointestinal adverse events with glucagon‐like peptide‐1 receptor agonists: Incidence and consequences
por: Horowitz, Michael, et al.
Publicado: (2017)

Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women
por: Pittas, Anastassios G., et al.
Publicado: (2010)

Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L
por: Zisman, Ariel, et al.
Publicado: (2018)

Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L
por: Blonde, Lawrence, et al.
Publicado: (2020)

Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study
por: Aroda, Vanita R., et al.
Publicado: (2021)

Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving
por: Chatterjee, Ranee, et al.
Publicado: (2010)

iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L study
por: Morea, Nicola, et al.
Publicado: (2020)

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
por: Aroda, Vanita R., et al.
Publicado: (2019)

Prediabetes and Alzheimer's Disease
por: Bitra, V. R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i9n7ivr8o83arivoscnqr9g365